Studying early markers for brittle bones in newborns
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This trial looks for tiny particles in the blood that might help doctors detect bone weakness in premature babies. It aims to find early signs of metabolic bone disease, which could lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be full-term, born between 37 and 41 weeks of pregnancy.
- Your baby must be less than 28 days old when joining the study.
- Your baby must not have had a blood transfusion or surgery.
- Your baby must not have any birth defects, inherited metabolic diseases, or intestinal problems.
- Your baby must not have received nutrition through a vein (intravenous nutrition).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children who may have genetic (inherited) or metabolic (body chemistry) problems, including newborn screening and episodes of trouble. The goal is to better understand these conditions and identify children who may benefit from further care.
This trial studies whether a treatment made from tiny cell packets (exosomes) can help protect the brain in extremely low birth weight, very premature newborns. It’s meant to test whether the approach is safe and may reduce brain-related harm from prematurity.
This study will collect urine from very premature or very low birth weight babies to look for patterns in natural chemicals (biomarkers). The goal is to find early clues about their health that could lead to better care.
This study looks for new markers and treatment targets for osteoporosis by comparing bone tissue from women with a broken hip (due to weak bones) and women getting a hip replacement for arthritis. You may be eligible if you are postmenopausal and have one of these hip conditions.
This study uses a simple blood spot and urine test to look for chemical signs of rare metabolic diseases. It aims to improve early detection and understanding of these conditions across all ages, including healthy individuals.
This study looks at microscopic particles called extracellular vesicles in the umbilical cord blood of babies born before 28 weeks. Researchers want to see if these particles can help predict severe health problems or death, and eventually improve care for extremely premature newborns.
Hear when a new Exosomes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.